Cargando…
Prediction of Microscopic Metastases in Patients with Metachronous Oligo-Metastases after Curative Treatment of Non-Small Cell Lung Cancer: A Microsimulation Study
SIMPLE SUMMARY: Many patients with metachronous oligo-metastases in non-small cell lung cancer have their recurrences surgically removed, although the 5-year recurrence-free survival of this group is 16%. This does not provide any benefit for patients with additional undetected metastases. Therefore...
Autores principales: | Wolff, Henri B., Alberts, Leonie, Kastelijn, Elisabeth A., Verstegen, Naomi E., El Sharouni, Sherif Y., Schramel, Franz M. N. H., Vos, Rein, Coupé, Veerle M. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070977/ https://www.ncbi.nlm.nih.gov/pubmed/33919930 http://dx.doi.org/10.3390/cancers13081884 |
Ejemplares similares
-
Cost-Effectiveness of Surveillance Scanning Strategies after Curative Treatment of Non–Small-Cell Lung Cancer
por: Wolff, Henri B., et al.
Publicado: (2020) -
Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC
por: Sluiter, Nina R., et al.
Publicado: (2018) -
Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma
por: Lee, So Jung, et al.
Publicado: (2020) -
Curative Resection for Metachronous Pulmonary Metastases from Colorectal Cancer: Analysis of Survival Rates and Prognostic Factors
por: Ihn, Myong Hoon, et al.
Publicado: (2017) -
The different clonal origins of metachronous and synchronous metastases
por: Gofrit, Ofer N., et al.
Publicado: (2023)